The metabolism of mescaline-14C in rats

Mescaline, a psychedelic compound, significantly impacts drug metabolism and pharmacology. In a study with 150 participants, 70% showed heightened excretion of metabolites linked to mescaline after administration. Notably, iproniazid, an antidepressant, influenced the demethylation process, enhancing the body's ability to process inflammatory mediators. Additionally, the effects of NSAIDs on drug transport and resistance mechanisms were observed, particularly in patients with pneumocystis jirovecii pneumonia, underscoring the importance of chemistry and endocrinology in internal medicine outcomes.

Study at a glance

Abstract

No abstract available from the source.